Here are the latest quarterly results of GLAND PHARMA. For more details, see the GLAND PHARMA financial fact sheet and GLAND PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 11,030 | 8,569 | 10,444 | 9,383 | 7,850 | 12,087 | 13,734 | 15,452 | |
Other income | Rs m | 652 | 744 | 656 | 615 | 389 | 375 | 532 | 374 | |
Turnover | Rs m | 11,682 | 9,313 | 11,100 | 9,998 | 8,240 | 12,462 | 14,266 | 15,825 | |
Expenses | Rs m | 7,547 | 5,870 | 7,476 | 6,487 | 6,166 | 9,147 | 10,493 | 11,888 | |
Gross profit | Rs m | 3,484 | 2,699 | 2,969 | 2,896 | 1,120 | 2,940 | 3,241 | 3,564 | |
Depreciation | Rs m | 311 | 349 | 367 | 376 | 375 | 653 | 813 | 1,053 | |
Interest | Rs m | 20 | 9 | 17 | 26 | 22 | 49 | 60 | 53 | |
Profit before tax | Rs m | 3,805 | 3,085 | 3,241 | 3,109 | 1,112 | 2,613 | 2,899 | 2,832 | |
Tax | Rs m | 946 | 793 | 828 | 789 | 325 | 672 | 958 | 913 | |
Profit after tax | Rs m | 2,859 | 2,292 | 2,412 | 2,319 | 787 | 1,941 | 1,941 | 1,919 | |
Gross profit margin | % | 31.6 | 31.5 | 28.4 | 30.9 | 14.3 | 24.3 | 23.6 | 23.1 | |
Effective tax rate | % | 24.9 | 25.7 | 25.6 | 25.4 | 29.2 | 25.7 | 33.0 | 32.2 | |
Net profit margin | % | 25.9 | 26.7 | 23.1 | 24.7 | 10.0 | 16.1 | 14.1 | 12.4 | |
Diluted EPS | Rs | 17.4 | 13.9 | 14.6 | 14.1 | 4.8 | 11.8 | 11.8 | 11.6 | |
Diluted EPS (TTM) | Rs | 73.6 | 66.2 | 62.5 | 60.0 | 47.4 | 45.3 | 42.4 | 40.0 | |
Subscriber Feature |
Indian share markets continued the momentum as the session progressed and ended higher.